Lena-Maria Engström

Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

Michael Grövdal, Mohsen Karimi, Rasheed Khan et al. · British Journal of Haematology · 2010 · 60 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

Michael Grövdal, Rasheed Khan, Anni Aggerholm et al. · Clinical Cancer Research · 2007 · 55 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Measurement of iron and zinc isotopes in human whole blood: Preliminary application to the study of HFE genotypes

Anna Stenberg, Dmitry Malinovsky, Björn Öhlander et al. · Journal of Trace Elements in Medicine and Biology · 2005 · 49 citations

Medicine, Genetics, Physiology +10

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Michael Grövdal, Rasheed Khan, Anni Aggerholm et al. · Blood · 2008 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +10